Compare BridgeBio Pharma Inc (BBIO) vs VanEck JP Morgan EM Local Currency Bond ETF (EMLC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs VanEck JP Morgan EM Local Currency Bond ETF — how do they compare? BridgeBio Pharma Inc trades at $83.9 (market cap $16.36B), while VanEck JP Morgan EM Local Currency Bond ETF trades at $25.6. The key difference: BridgeBio Pharma Inc is trading nearer its 52-week high, VanEck JP Morgan EM Local Currency Bond ETF nearer its low. Which is the better fit depends on your goals.
| BBIO | EMLC | |
|---|---|---|
Market Cap | $16.36B | — |
Sector | Health | Fixed Income |
52-Week High | $90.17 | $26.59 |
52-Week Low | $47.29 | $24.83 |
Enterprise Value | $18.14B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About VanEck JP Morgan EM Local Currency Bond ETF
EMLC invests in local currency-denominated government bonds from emerging market countries. It provides exposure to sovereign debt in nations like Brazil, Mexico, and South Africa, allowing investors to gain from high yields and potential local currency appreciation.
Read more on EMLC →
